Related content

Quality of Life after Treatment for Gynecologic Malignancies: A Pilot Study in an Outpatient Clinic

By Miller B.E.   Pittman B.   Case D.   McQuellon R.P.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 178-184

Academic Press

Access to resources Recommend Favorite

Risk of disability pension for patients diagnosed with haematological malignancies: A register-based cohort study

By Horsboel Trine A.   Nielsen Claus V.   Andersen Niels T.   Nielsen Bendt   de Thurah Annette  

Acta Oncologica, Vol. 53, Iss. 6, 2014-06 ,pp. : 724-734

Informa Healthcare

Access to resources Recommend Favorite

Variation in survival of adult patients with haematological malignancies in Europe since 1978

By Carli P.M.   Coebergh J.W.W.   Verdecchia A.  

European Journal of Cancer, Vol. 34, Iss. 14, 1998-12 ,pp. : 2253-2263

Elsevier

Access to resources Recommend Favorite

Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies

By          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1742-1748

Spandidos Publications

Access to resources Recommend Favorite

Follow-up of patients with haematological malignancies and their families in regional, rural and remote Queensland: the GPs' perspective

By McGrath P.  

Supportive Care in Cancer, Vol. 9, Iss. 3, 2001-05 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite